CIA
PROF

Concurrent Investment Advisors’s Profound Medical PROF Stock Holding History

Concurrent Investment Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+21,657
New +$146K ﹤0.01% 1996

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Concurrent Investment Advisors's PROF Position: Q2 2026 in Review

Concurrent Investment Advisors opened a new position in Profound Medical (PROF) in Q2 2026: 21,657 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #1996 among its holdings.

56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Concurrent Investment Advisors held 21,657 shares of Profound Medical worth $144K as of Q2 2026.
  • Profound Medical was a new Concurrent Investment Advisors position in Q2 2026.
  • Profound Medical made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1996 holding.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.